Genetic alteration analysis in PT-DLBCL reveals significant prognostic effects of chromosomal abnormalities and MSI in DNA sequences and TP53 RNA variants with high VAFs. The gene discussed is TP53; the disease is diffuse large B-cell lymphoma.